Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesChange in InventoryChange in ReceivablesExchange Rate EffectNet Income
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pharming (PHAR) Cash from Investing Activities (2020 - 2023)

Historic Cash from Investing Activities for Pharming (PHAR) over the last 5 years, with Q2 2023 value amounting to -$67.3 million.

  • Pharming's Cash from Investing Activities fell 115181.42% to -$67.3 million in Q2 2023 from the same period last year, while for Jun 2023 it was -$67.2 million, marking a year-over-year decrease of 161077.02%. This contributed to the annual value of -$2.6 million for FY2021, which is 8358.82% up from last year.
  • As of Q2 2023, Pharming's Cash from Investing Activities stood at -$67.3 million, which was down 115181.42% from -$375000.0 recorded in Q4 2022.
  • In the past 5 years, Pharming's Cash from Investing Activities registered a high of $6.4 million during Q2 2022, and its lowest value of -$67.3 million during Q2 2023.
  • In the last 5 years, Pharming's Cash from Investing Activities had a median value of -$1.8 million in 2020 and averaged -$9.5 million.
  • Its Cash from Investing Activities has fluctuated over the past 5 years, first crashed by 1562719.2% in 2021, then skyrocketed by 18292.26% in 2022.
  • Over the past 5 years, Pharming's Cash from Investing Activities (Quarter) stood at -$27.9 million in 2019, then skyrocketed by 99.94% to -$16309.3 in 2020, then crashed by 15627.19% to -$2.6 million in 2021, then surged by 85.38% to -$375000.0 in 2022, then crashed by 17834.13% to -$67.3 million in 2023.
  • Its Cash from Investing Activities stands at -$67.3 million for Q2 2023, versus -$375000.0 for Q4 2022 and -$6.0 million for Q3 2022.